Skip to main content
User account menu
Log in
Reset password
Search
Secondary navigation
About Us
Community Outreach
News
Main Navigation
Network
Research
People
Meetings
Resources
Breadcrumb
HIV / AIDS in the News
HIV-AIDS
Back to top
Twice-Yearly Shot Protects At-Risk Women Against HIV - leader-call.com
Wed, 07/24/2024 - 07:21
Ongoing Stigma Remains a Major Obstacle in the Fight Against HIV | AIDS 2024 - Managed Healthcare Executive
Wed, 07/24/2024 - 06:41
A twice-yearly injection offers 100% protection against HIV in trial of young women - Africanews English
Wed, 07/24/2024 - 06:12
‘Revolutionary’: HIV shot offers 100% protection against new infections in women - South China Morning Post
Wed, 07/24/2024 - 05:47
Cost of HIV prevention injection expected to go from $42,250 to around $40 - Israel Hayom
Wed, 07/24/2024 - 05:36
Cost of HIV prevention injection expected to go from $42,250 to around $40 - Israel Hayom
Wed, 07/24/2024 - 05:36
Experts say a twice-yearly injection that offers 100% protection against HIV is 'stunning' - MSN
Wed, 07/24/2024 - 05:02
Experts say a twice-yearly injection that offers 100% protection against HIV is 'stunning' - Bozeman Daily Chronicle
Wed, 07/24/2024 - 04:37
Experts say a twice-yearly injection that offers 100% protection against HIV is ‘stunning’ - The Hill
Wed, 07/24/2024 - 04:37
Woman needed HIV test after GP used old genital swab - BBC.com
Wed, 07/24/2024 - 04:36
Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women - nejm.org
Wed, 07/24/2024 - 04:32
Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women - nejm.org
Wed, 07/24/2024 - 04:32
HIV prevention may only require two injections per year - Science News Magazine
Wed, 07/24/2024 - 04:30
HIV prevention may only require two injections per year - Science News Magazine
Wed, 07/24/2024 - 04:30
Full Efficacy and Safety Results for Gilead Investigational Twice-Yearly Lenacapavir for HIV Prevention Presented at AIDS 2024 - Business Wire
Wed, 07/24/2024 - 04:30
Full Efficacy and Safety Results for Gilead Investigational Twice-Yearly Lenacapavir for HIV Prevention Presented at AIDS 2024 - Business Wire
Wed, 07/24/2024 - 04:30
Full Efficacy and Safety Results for Gilead Investigational Twice-Yearly Lenacapavir for HIV Prevention Presented at AIDS 2024 - Yahoo Finance
Wed, 07/24/2024 - 04:30
Germany hosts over 10,000 people for conference on HIV/AIDS - VOA Africa
Wed, 07/24/2024 - 04:00
Germany hosts over 10,000 people for conference on HIV/AIDS - VOA Africa
Wed, 07/24/2024 - 04:00
HIV medicine that costs $42,000 could be made for just $40 with profits - Business Standard
Wed, 07/24/2024 - 03:26
HIV medicine that costs $42,000 could be made for just $40 with profits - Business Standard
Wed, 07/24/2024 - 03:26
HIV in Wisconsin - Wisconsin Department of Health Services
Wed, 07/24/2024 - 03:00
Day 3 at AIDS 2024: Research Updates, HIV Criminalization Laws, and AI - HIV.gov
Wed, 07/24/2024 - 03:00
Experts laud injection that reportedly offers 100% protection against HIV/AIDS - Fox News
Wed, 07/24/2024 - 03:00
People living with HIV - UNAIDS
Wed, 07/24/2024 - 03:00
The Companies Making the Most Money with HIV/AIDS Drugs - Statista
Wed, 07/24/2024 - 03:00
Twice-yearly shot proves successful at preventing HIV infection among women, trial data shows - CNN
Wed, 07/24/2024 - 03:00
The Companies Making the Most Money with HIV/AIDS Drugs - Statista
Wed, 07/24/2024 - 03:00
People living with HIV - UNAIDS
Wed, 07/24/2024 - 03:00
Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women - nejm.org
Wed, 07/24/2024 - 03:00
Pagination
First page
« First
Previous page
‹‹
…
Page
57
Page
58
Page
59
Page
60
Current page
61
Page
62
Page
63
Page
64
Page
65
…
Next page
››
Last page
Last »